Untuk Kegunaan UKM sahaja
For UKM use only
PEGAWAI PERUBATAN
| Sarjana Muda , UNIVERSITY OF LEICESTER , 2007 |
| Nik Nuratiqah Nik Abeed, Boon Hau Ng, Hilawati Yusof, Marfu'ah Nik Ezzamudden, Andrea Yu Lin Ban, Mohamed Faisal Abdul Hamid. (2023). Massive Lung Metastasis Secondary To Germ Cell Testicular Tumor. - Respirology. 327. |
| Siti Nur Akmal Ghazali, Caryn Mei Hsien Chan, Marfuah Nik Eezamuddeen, Hanani Abdul Manan Dan Noorazrul Yahya. (2023). Quality Of Life For Head And Neck Cancer Patients: A 10 Year Bibliographic Analysis. - Cancers. 1-13. |
| Nik Nuratiqah Nik Abeed, Boon Hau Ng, Hilawati Yusof, Marfu'ah Nik Ezzamudden, Andrea Yu Lin Ban, Mohamed Faisal Abdul Hamid. (2023). Massive Lung Metastasis Secondary To Germ Cell Testicular Tumor. - Respirology. 327. |
| Siti Nur Akmal Ghazali, Caryn Mei Hsien Chan, Marfuah Nik Eezamuddeen, Hanani Abdul Manan Dan Noorazrul Yahya. (2023). Quality Of Life For Head And Neck Cancer Patients: A 10 Year Bibliographic Analysis. - Cancers. 1-13. |
| Ramesh Kumar, Beehong Soon, Fuad Ismail, Marfuah Nik Ezzamudden, Shahizon Azura Mohamed Mukari, Aida Widure Mustapha Mohd Mustapha, Aida Hani Mohd Kalok, Norlia Abdullah, Ian Paddick, Siti Khadijah Hamsan. (2023). Gamma Knife Radiosurgery: A Safe And Effective Treatment For Brain Metastases In Pregnancy. - The 8th Meeting Of The Asian Leksell Gamma Knife Society. 135--. |
| Nur Syafiqah Abd Hakim, Azyani Yahya, Marfuah Nik Eezamuddeen, Nurul Aina Fatiha Jamli, Puteri Hanis Nafisah Megat Kamil azmi,nadiah Abu. (2023). Clinical Validation Of A Circanapc7 Basescope Probe For The Detection Of Folfox Chemoresistant Colorectal Cancer Via In Situ Hybridization. - 9th Regional Conference On Molecular Medicine (rcmm) In Conjunction With 5th National Conference For Cancer Research (nccr). 1. |
| Randomized, Multicenter, Multinational, Double-Blind Study to Compare the Pharmacokinetics, Efficacy, Safety and Immunogenicity of MB12 (Proposed Pembrolizumab Biosimilar) versus Keytruda® in Combination with Chemotherapy for the Treatment of Patients , Ketua Projek , 17-04-2025 sehingga 16-05-2027 , Antarabangsa |
| A Randomized, Double-blind Study to Compare the Pharmacokinetics Between ABP 234 and Keytruda® (Pembrolizumab) in Subjects with Early-stage Non-squamous Non-small Cell Lung Cancer as Adjuvant Treatment Following Resection and Platinum-based Chemotherapy , Ketua Projek , 25-07-2024 sehingga 24-05-2028 , Antarabangsa |
| A Randomized, Double-Blind Study to Compare Efficacy, Pharmacokinetics, Safety, and Immunogenicity Between ABP 234 and Keytruda® (Pembrolizumab) in Subjects with Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer , Ketua Projek , 03-07-2024 sehingga 02-07-2029 , Antarabangsa |
| A Phase 1b/2, Open-label, Randomized Study of Vudalimab in Combination With Chemotherapy or Pembrolizumab in Combination With Chemotherapy as First-line Treatment in Patients With Advanced Non-small Cell Lung Cancer , Ketua Projek , 13-05-2024 sehingga 12-08-2027 , Antarabangsa |
| Elacestrant versus Standard Endocrine Therapy inWomen and Men with Node-positive, Estrogen Receptor-positive, HER2-negative, Early Breast Cancer withHigh Risk of Recurrence—A Global, Multicenter, Randomized, Open-label Phase 3 Study (ELEGANT) , Penyelidik Bersama , 09-01-2025 sehingga 08-01-2033 , Antarabangsa |
| An open-label, multi-center, single arm, rollover study of GME751 (proposed pembrolizumab biosimilar) in participants who are eligible for continued pembrolizumab treatment after participation in CGME751A12101 or CGME751A12301 studies , Penyelidik Bersama , 20-11-2024 sehingga 19-05-2028 , Antarabangsa |
| A Phase 2/3, Randomized Study of INBRX-106 Combined With Pembrolizumab Versus Pembrolizumab as First-Line Treatment for Patients With Recurrent or Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (HNSCC) Expressing PD-L1 (CPS ≥20) (HexAgon-HN) , Penyelidik Bersama , 24-10-2024 sehingga 23-10-2029 , Antarabangsa |
| A Randomized, Open-label Phase 3 Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and FOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer , Penyelidik Bersama , 26-09-2024 sehingga 25-11-2028 , Antarabangsa |
| A Phase III, Open-label, Sponsor-blind, Randomized Study of Dato-DXd With or Without Osimertinib Versus Platinum-based Doublet Chemotherapy for Participants with EGFR-mutated Locally Advanced or Metastatic Non-small Cell Lung Cancer whose Disease has... , Penyelidik Bersama , 26-09-2024 sehingga 25-03-2028 , Antarabangsa |
| A Randomized, Open-Label Phase 2/3 Study of BT8009 as Monotherapy or in Combination in Participants with Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2) , Penyelidik Bersama , 25-07-2024 sehingga 24-03-2031 , Antarabangsa |
| An fMRI Study Of Default Mode Network Between Head And Neck Cancer Patients With Different Alterations In Quality Of Life After Radiotherapy , Penyelidik Bersama , 22-02-2024 sehingga 21-02-2027 , Kebangsaan |
| A Randomized, Double-Blind Study Evaluating the Efficacy, Safety, and Immunogenicity of ABP 206 Compared with OPDIVO® (Nivolumab) in Subjects with Treatment-Naïve Unresectable or Metastatic Melanoma , Penyelidik Bersama , 04-01-2024 sehingga 03-10-2025 , Antarabangsa |
| A randomized, double-blind, parallel-group study to compare efficacy, safety, and immunogenicity of GME751 (proposed pembrolizumab biosimilar) and EU-authorized Keytruda® in adult participants with untreated metastatic non-squamous non-small cell lung can , Penyelidik Bersama , 21-12-2023 sehingga 20-06-2027 , Antarabangsa |
| A Global, Phase 3, Randomized, Multicenter, Open-Label Study to Investigate the Efficacy and Safety of Furmonertinib Compared to Platinum-Based Chemotherapy as First-LineTreatment for Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cance , Penyelidik Bersama , 27-07-2023 sehingga 26-05-2029 , Antarabangsa |
| A Randomized, Double-blind Study Evaluating Pharmacokinetic Similarity of ABP 206 Compared With OPDIVO® (Nivolumab) in Resected Stage III or Stage IV Melanoma Subjects in the Adjuvant Setting , Penyelidik Bersama , 22-06-2023 sehingga 21-08-2025 , Antarabangsa |
| Phase 1 Study Investigating The Safety, Tolerability, Pharmacokinetics, And Preliminary Antitumor Activity Of The Anti‑OX40 Agonist Monoclonal Antibody BGB-A445 In Combination With The Anti-PD-1 Monoclonal Antibody Tislelizumab In Patients With Advanced S , Penyelidik Bersama , 10-11-2022 sehingga 09-11-2025 , Antarabangsa |
| Delineating the Immunogenic Roles of FOLFOX-induced Extracellular Vesicles via the Toll-Like Receptor 4 (TLR4) Pathway in Colorectal Cancer , Penyelidik Bersama , 01-09-2022 sehingga 31-08-2025 , Kebangsaan |
| A Randomized, Open-Label, Phase 3 Study Of Cosibelimab (CK-301) In Combination With Platinum+Pemetrexed Chemotherapy In Subjects With First-Line Metastatic Non-Squamous Non-Small Cell Lung Cancer [Protocol No. CK-301-301] , Penyelidik Bersama , 10-06-2021 sehingga 09-06-2025 , Antarabangsa |
| Experiences of lung cancer patients in Malaysia , Ketua Projek , 16-03-2023 sehingga 15-03-2024 , Universiti |
| End-of-Life Communication: A Malaysian Survey among Oncology Doctors , Ketua Projek , 27-01-2022 sehingga 26-05-2023 , Kebangsaan |
| Immuno-capture of Circulating Galectin 9-Bound Extracellular Vesicles using Superparamagnetic Beads via Conventional Flow Cytometry , Penyelidik Bersama , 16-01-2023 sehingga 15-07-2024 , Universiti |
| Design, Efficacy Evaluation and Clinical Validation of a circANAPC7 BaseScope Probe for the Detection of FOLFOX Chemoresistant Colorectal Cancer via In Situ Hybridization , Penyelidik Bersama , 01-07-2022 sehingga 30-06-2024 , Kebangsaan |
| SOX9 and NANOG Expression as a Predictive Marker for Chemotherapy Response In Triple-Negative Breast Cancer , Penyelidik Bersama , 11-11-2021 sehingga 10-11-2024 , Universiti |
| Creation of a Breast Cancer Database for Hospital Canselor Tuanku Muhriz , Penyelidik Bersama , 26-08-2021 sehingga 25-04-2023 , Universiti |
| CLINICOPATHOLOGICAL CONFERENCE (CPC) DEPARTMENT OF MEDICINE: STUMBLING IN SHADOWS. UNRAVELLING THE PUZZLE OF A MIDDLE-AGED MAN’S COLLISION COURSE AND SHADOWY CHEST , 29-05-2024 sehingga 29-05-2024 , Pusat Pengajian / Jabatan / Pusat Penyelidikan / Unit |
| CLINICOPATHOLOGICAL CONFERENCE (CPC) DEPARTMENT OF OBSTETRIC & GYNAECOLOGY: PREECLAMPSIA IN SERONEGATIVE APLS: A BATTLE NEVER WON? , 24-01-2024 sehingga 24-01-2024 , Fakulti / Institut / Pusat Perkhidmatan |
| Clinico-Pathological Conference (CPC) Hepatobiliary Surgery unit, Dept. of Surgery, UKM Faculty of Medicine: Epigastric pain may not always equate gastritis , 14-12-2022 sehingga 14-12-2022 , Pusat Pengajian / Jabatan / Pusat Penyelidikan / Unit |
| Clinico-Pathological Conference (CPC) by the Department of Otorhinolaryngology, Head & Neck Surgery: WHY FACIAL NUMBNESS MATTERS? , 09-11-2022 sehingga 09-11-2022 , Pusat Pengajian / Jabatan / Pusat Penyelidikan / Unit |
| Grand Clinico-Pathological Conference (Grand CPC) Upper Gastrointestinal Surgery, Dept. of Surgery: Between The Devil and The Deep Blue Sea- A Diagnostic Conundrum of Dual Pathology , 02-11-2022 sehingga 02-11-2022 , Fakulti / Institut / Pusat Perkhidmatan |
| HEAD & NECK ONCOLOGY AND SURGERY MASTER CLASS 2024 , 19-07-2024 sehingga 20-07-2024 , Universiti |
| JAWATANKUASA PENYEDIAAN DAN PENILAIAN SPESIFIKASI BAGI PROSES SEBUTHARGA UNTUK MEMBEKAL, MENGHANTAR, MENUKAR DAN MEMASANG “SUMBER RADIOAKTIF IRIDIUM-192 (Ir-192)” , 01-03-2024 sehingga 30-09-2024 , Pusat Pengajian / Jabatan / Pusat Penyelidikan / Unit |
| JAWATANKUASA PROGRAM MINGGU KESEDARAN KANSER PAYUDARA (PINKTOBER) 2024 , 30-09-2024 sehingga 04-10-2024 , Pusat Pengajian / Jabatan / Pusat Penyelidikan / Unit |
| JAWATANKUASA TENDER PROJEK SISTEM LINEAR ACCELERATOR JABATAN RADIOTERAPI DAN ONKOLOGI, HCTM , 09-03-2023 sehingga 31-12-2025 , Pusat Pengajian / Jabatan / Pusat Penyelidikan / Unit |
| LANTIKAN JK PENILAI PAKAR BIDANG BAGI PEMBENTANGAN CADANGAN PENYELIDIKAN (PROPOSAL) PELAJAR SISWAZAH EMESTER 2, SESI AKADEMIK 2022/2023 FAKULTI SAINS KESIHATAN, UKM , 08-08-2023 sehingga 08-08-2023 , Fakulti / Institut / Pusat Perkhidmatan |
| Pemeriksa Dalam Untuk Menilai Tesis Ijazah Sarjana Sains Kesihatan , 04-06-2024 sehingga 04-06-2024 , Fakulti / Institut / Pusat Perkhidmatan |
| UKMMC Breast Cancer Update: A Webinar Series , 20-02-2021 sehingga 22-05-2021 , Universiti |